ライフサイエンスコーパス: vaginal dryness

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 en about possible remedies, particularly for vaginal dryness.

2 Hot flashes, night sweats, and vaginal dryness.

3 menopausal symptoms, such as hot flashes or vaginal dryness.

4 Providing advice on treating vaginal dryness and brief sexual counseling can often al

5 Vaginal dryness and dyspareunia are significant estrogen

6 e placebo appear to substantially ameliorate vaginal dryness and dyspareunia in breast cancer survivo

7 presentation, most patients complained about vaginal dryness and dyspareunia with impairment in sexua

8 ts seem to moderately decrease occurrence of vaginal dryness and dyspareunia.

9 or little desire, 80% reported problems with vaginal dryness, and 62% reported pain or discomfort dur

10 Ongoing treatment, vaginal dryness, and feeling unprepared for the impact o

11 rolling for sexual problems at prediagnosis, vaginal dryness, and lower perceived sexual attractivene

12 d menopausal symptoms including hot flashes, vaginal dryness, and sexual dysfunction.

13 enopause, but only vasomotor dysfunction and vaginal dryness are consistently associated with this ti

14 inal discharge than tamoxifen, but with more vaginal dryness, bone/muscle aches, and difficulty sleep

15 ductions in the frequency of hot flashes and vaginal dryness but no significant reduction in night sw

16 During the first 4 weeks, average vaginal dryness decreased by 62% and 64% in the placebo

17 ge I to III BC taking AIs with self-reported vaginal dryness, dyspareunia, or decreased libido were r

18 ctors of sexual health, several are mutable (vaginal dryness, emotional well-being, body image, the q

19 atients on exemestane plus OFS reported more vaginal dryness, greater loss of sexual interest, and di

20 Hispanic women reported urine leakage, vaginal dryness, heart pounding, and forgetfulness more

21 The distribution of women not reporting vaginal dryness in the past month improved significantly

22 as associated with experiencing dyspareunia, vaginal dryness, low libido, and not experiencing orgasm

23 0; 95% confidence interval [CI], 1.63-2.21), vaginal dryness (LR+ range, 1.48-3.79), high follicle-st

24 erican women reported vasomotor symptoms and vaginal dryness more (odds ratios = 1.17-1.63) but urine

25 negative reactions during sex (P = .02) and vaginal dryness or tightness (P = .046).

26 reported more bone/muscle aches (P < .0001), vaginal dryness (P = .0004), and difficulty sleeping (P

27 ual dysfunction, including decreased libido, vaginal dryness, pain with intercourse, decreased genita

28 cold sweats and vaginal discharge, yet more vaginal dryness, painful intercourse, and loss of sexual

29 , and the common significant predictors were vaginal dryness, past chemotherapy use, and having a new

30 ence of changes, -0.79 [-1.35 to -0.23]) and vaginal dryness score (pooled mean difference of changes

31 changes, -1.31 [95% CI, -2.02 to -0.61]) and vaginal dryness score (pooled mean difference of changes

32 st and sleep disturbance at 6 months, and by vaginal dryness up to 60 months.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。